BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+4%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$170M
AUM Growth
+$170M
(+11%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
8.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$14.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 40.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $85.4M | 50.34% | 8,930,237 | – | – |
|
2
InflaRx
IFRX
$108M
| $54.1M | 31.91% | 1,876,413 | – | – |
|
|
MRNS
3
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $15.2M | 8.96% | 3,977,453 | – | – |
|
|
4
Solid Biosciences
SLDB
$427M
| $14.9M | 8.8% | +1,989,444 | New | +$14.9M |
|